The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2SEVENTY BIO INC | COMMON STOCK | 901384107 | 13,201 | 1,408,901 | SH | SOLE | 1,408,901 | 0 | 0 | |||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 11,166 | 701,402 | SH | SOLE | 701,402 | 0 | 0 | |||
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 2,406 | 5,347,689 | SH | SOLE | 5,347,689 | 0 | 0 | |||
ANNEXON INC | COM | 03589W102 | 25,264 | 4,886,616 | SH | SOLE | 4,886,616 | 0 | 0 | |||
APTINYX INC | COM | 03836N103 | 2,537 | 8,891,758 | SH | SOLE | 8,891,758 | 0 | 0 | |||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 44,400 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | |||
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 11,956 | 2,485,638 | SH | SOLE | 2,485,638 | 0 | 0 | |||
C4 THERAPEUTICS INC | COM STK | 12529R107 | 9,689 | 1,642,210 | SH | SOLE | 1,642,210 | 0 | 0 | |||
CARA THERAPEUTICS INC | COM | 140755109 | 28,955 | 2,696,030 | SH | SOLE | 2,696,030 | 0 | 0 | |||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 42,192 | 2,305,558 | SH | SOLE | 2,305,558 | 0 | 0 | |||
CTI BIOPHARMA CORP | COM | 12648L601 | 22,702 | 3,777,308 | SH | SOLE | 3,777,308 | 0 | 0 | |||
DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | 41,656 | 3,915,000 | SH | SOLE | 3,915,000 | 0 | 0 | |||
EQRX INC | COM | 26886C107 | 24,609 | 10,003,573 | SH | SOLE | 10,003,573 | 0 | 0 | |||
INVIVYD INC | COM | 00534A102 | 2,906 | 1,937,207 | SH | SOLE | 1,937,207 | 0 | 0 | |||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 5,696 | 1,431,058 | SH | SOLE | 1,431,058 | 0 | 0 | |||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 50,769 | 8,663,673 | SH | SOLE | 8,663,673 | 0 | 0 | |||
NATERA INC | COM | 632307104 | 56,238 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | |||
NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 3,600 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | |||
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 90,470 | 8,300,000 | SH | SOLE | 8,300,000 | 0 | 0 | |||
NEWAMSTERDAM PHARMA COMPANY | *W EXP 11/22/202 | N62509117 | 86 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
NURIX THERAPEUTICS INC | COM | 67080M103 | 20,015 | 1,822,883 | SH | SOLE | 1,822,883 | 0 | 0 | |||
NUVALENT INC | COM | 670703107 | 106,531 | 3,577,267 | SH | SOLE | 3,577,267 | 0 | 0 | |||
PHARVARIS N V | COM | N69605108 | 35,782 | 3,180,601 | SH | SOLE | 3,180,601 | 0 | 0 | |||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 25,796 | 2,364,410 | SH | SOLE | 2,364,410 | 0 | 0 | |||
RAPID MICRO BIOSYSTEMS INC | CLASS A COM | 75340L104 | 9,531 | 8,434,560 | SH | SOLE | 8,434,560 | 0 | 0 | |||
SAVARA INC | COM | 805111101 | 18,015 | 11,622,598 | SH | SOLE | 11,622,598 | 0 | 0 | |||
SOLID BIOSCIENCES INC | COM NEW | 83422E204 | 16,842 | 3,130,422 | SH | SOLE | 3,130,422 | 0 | 0 | |||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 125,662 | 4,831,307 | SH | SOLE | 4,831,307 | 0 | 0 | |||
SYROS PHARMACEUTICALS INC | COM NEW | 87184Q206 | 7,628 | 2,124,694 | SH | SOLE | 2,124,694 | 0 | 0 | |||
TANGO THERAPEUTICS INC | COM | 87583X109 | 13,933 | 1,921,790 | SH | SOLE | 1,921,790 | 0 | 0 | |||
THIRD HARMONIC BIO INC | COM | 88427A107 | 4,952 | 1,151,657 | SH | SOLE | 1,151,657 | 0 | 0 | |||
X4 PHARMACEUTICALS INC | COM | 98420X103 | 12,117 | 12,202,510 | SH | SOLE | 12,202,510 | 0 | 0 | |||
XILIO THERAPEUTICS INC | COM | 98422T100 | 7,547 | 2,805,413 | SH | SOLE | 2,805,413 | 0 | 0 |